A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

NCT00443170 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Anaemia

Interventions

DRUG: GSK626616, placebo, midazolam
DRUG: omeprazole, caffeine, flurbiprofen, rosiglitazone

Sponsor

GlaxoSmithKline